Artivion
Builds devices, sealants, valves, and preservation services for cardiac and vascular surgery.
$26.77
After-hours close+0.03 (+0.11%)
At close$26.74(+0.26%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions —Insiders 5.13%
Shares outstanding 48.54M · Float 46.07M · 94.9% free float
Institutions13F
No 13F holders on record.
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 12.70% | 5.98M | 13G | Oct 17, 2025 ↗ |
| Nomura Asset Management International Inc. | 5.50% | 2.61M | 13G | Feb 17, 2026 ↗ |
| FMR LLC | 5.40% | 2.29M | 13G | Aug 6, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| James P. Mackin | officer: President & CEO | 877.3K | 1.81% | Aug 20, 2026 |
| John E. Davis | officer: Chief Commercial Officer | 230.8K | 0.48% | Mar 4, 2026 |
| Lance A. Berry | officer: EVP, COO, CFO & Treasurer | 210.1K | 0.43% | Aug 17, 2026 |
| Jean F. Holloway | officer: SVP, General Counsel | 184.1K | 0.38% | Aug 12, 2026 |
| Daniel J. Bevevino | director | 157.6K | 0.32% | May 20, 2026 |
| Thomas F. Ackerman | director | 157.5K | 0.32% | May 20, 2026 |
| Amy Horton | officer: VP, Chief Accounting Officer | 139.1K | 0.29% | Mar 4, 2026 |
| Jon W. Salveson | director | 137.4K | 0.28% | May 20, 2026 |
| James Bullock | director | 76.2K | 0.16% | May 20, 2026 |
| Jeffrey H. Burbank | director | 61.4K | 0.13% | May 20, 2026 |
32 people have not refiled in the last 18 months (3.38M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 19, 2026 | James P. Mackinofficer: President & CEO | Sale | 70,000 | $28.96 | 877,275 |
| Aug 14, 2026 | Lance A. Berryofficer: EVP, COO, CFO & Treasurer | Sale | 715 | $28.55 | 210,112 |
| Aug 14, 2026 | Andrew M. Greenofficer: SVP, Regulatory and Quality | Sale | 616 | $28.55 | 59,643 |
| Aug 12, 2026 | Jean F. Hollowayofficer: SVP, General Counsel | Sale | 977 | $28.49 | 184,118 |
| Jun 11, 2026 | Andrew M. Greenofficer: SVP, Regulatory and Quality | Sale · 2 lots | 44,001 | $20.70 | 60,259 |
| Mar 3, 2026 | James P. Mackinofficer: President & CEO | Sale | 17,887 | $37.78 | 947,275 |
| Mar 3, 2026 | Lance A. Berryofficer: EVP, COO, CFO & Treasurer | Sale | 6,316 | $37.78 | 210,827 |
| Mar 3, 2026 | John E. Davisofficer: Chief Commercial Officer | Sale | 4,573 | $37.78 | 230,794 |
| Mar 3, 2026 | Marshall S. Stantonofficer: SVP, Clinical & MD Affair | Sale | 2,149 | $37.78 | 60,097 |
| Mar 4, 2026 | Jean F. Hollowayofficer: SVP, General Counsel | Sale | 8,962 | $38.00 | 185,095 |
CongressHouse and Senate disclosures
Not reported.